Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy

Biochim Biophys Acta. 2002 Dec 19;1573(3):216-24. doi: 10.1016/s0304-4165(02)00387-2.

Abstract

The myodystrophy (myd) mutation arose spontaneously and has an autosomal recessive mode of inheritance. Homozygous mutant mice display a severe, progressive muscular dystrophy. Using a positional cloning approach, we identified the causative mutation in myd as a deletion within the Large gene, which encodes a putative glycosyltransferase with two predicted catalytic domains. By immunoblotting, the alpha-subunit of dystroglycan, a key muscle membrane protein, is abnormal in myd mice. This aberrant protein might represent altered glycosylation of the protein and contribute to the muscular dystrophy phenotype. Our results are discussed in the light of recent reports describing mutations in other glycosyltransferase genes in several forms of human muscular dystrophy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cytoskeletal Proteins / metabolism
  • Cytoskeletal Proteins / physiology
  • Dystroglycans
  • Glycosylation
  • Humans
  • Membrane Glycoproteins / metabolism
  • Membrane Glycoproteins / physiology
  • Mice
  • Mice, Inbred mdx
  • Molecular Sequence Data
  • Muscular Dystrophies / enzymology*
  • Muscular Dystrophies / genetics
  • N-Acetylglucosaminyltransferases / genetics
  • N-Acetylglucosaminyltransferases / physiology*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology*
  • Phenotype

Substances

  • Cytoskeletal Proteins
  • DAG1 protein, human
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Dystroglycans
  • LARGE1 protein, human
  • N-Acetylglucosaminyltransferases